Market Overview

IMAX Corporation Reports Second Quarter 2018 Results

Share:

IMAX Corporation Reports Second Quarter 2018 Results

PR Newswire

NEW YORK, July 25, 2018 /PRNewswire/ --

IMAX Logo. (PRNewsFoto/IMAX Corporation)

HIGHLIGHTS

  • Strong financial results driven by compelling blockbuster content worldwide, global network expansion and ongoing cost discipline – three factors the Company anticipates will continue to drive earnings in the future.
  • Delivered Q2 2018 earnings per share and adjusted earnings per share of $0.12 and $0.30, respectively compared to a loss per share of $0.03 and adjusted earnings per share of $0.15, respectively in Q2 2017.
  • Studios' continued emphasis on blockbuster content, coupled with consumers' desire to experience that content in differentiated ways, drove IMAX global box office to $343 million in the second quarter, a 28% increase compared to Q2 2017 and, representing the Company's fifth consecutive period of quarterly box office growth.
  • Repurchased $33.0 million of shares in the second quarter at an average price of $22.01 per share, and repurchased $46 million of shares in the first half of 2018 at an average price of $21.54 per share.

IMAX Corporation (NYSE:IMAX) today reported second quarter 2018 revenues of $98.3 million, gross profit of $60.4 million and net income attributable to common shareholders of $7.6 million, which calculates to $0.12 per diluted share. Adjusted net income attributable to common shareholders for the second quarter was $19.0 million, which calculates to $0.30 per diluted share. Adjusted EBITDA per Credit Facility was $39.5 million. For reconciliations of reported results to non-GAAP financial results, and for the definition and reconciliation of Adjusted EBITDA per Credit Facility, please see the end of this press release.

"Building on our first quarter momentum, we continued to demonstrate the value of our differentiated consumer experience, expanding global footprint and focus on blockbuster content from around the world. These factors, coupled with our continued focus on controlling costs, helped drive second quarter adjusted EBITDA of $39.5 million, a 35% increase compared to the second quarter last year. Through the first six months of 2018, adjusted EBITDA is up 49% compared to the same period last year," said IMAX CEO Richard L. Gelfond. "Not only are studios emphasizing blockbuster-type content, consumers are increasingly seeking differentiated ways to experience that content. We believe IMAX is uniquely positioned to benefit from these trends, especially with the roll out of our new IMAX® with Laser experience, which we expect will further increase the differentiation of The IMAX Experience®."                                                             

Second Quarter 2018 Results

Network Update
During the quarter, the Company installed 31 theater systems, 30 of which were for new theater locations. The total IMAX® theater network consisted of 1,410 systems as of June 30, 2018, of which 1,314 were in commercial multiplexes. There were 635 theaters in backlog as of June 30, 2018, compared to the 580 in backlog as of June 30, 2017.

IMAX also signed contracts for 40 new theaters and 98 upgrades in the second  quarter of 2018.  For a breakdown of theater system signings, installations, network and backlog by type for the second quarter of 2018, please see the end of this press release.

Box Office Update
Gross box office from IMAX DMR® films increased 27.4% to $342.6 million in the second quarter of 2018 from $268.9 million in the second quarter of 2017. Gross box office was generated primarily by the exhibition of 14 films (10 new and 4 carryovers), as compared to 16 films (11 new and 5 carryovers) exhibited in the second quarter of 2017.

Second Quarter Consolidated Results
The gross margin across all segments in the second quarter of 2018 was $60.4 million, or 61.4% of total revenues, compared to $49.5 million, or 56.4% of total revenues, in the second quarter of 2017. Operating expenses (which includes SG&A, excluding stock-based compensation, plus R&D) were $30.3 million in the quarter.

Gelfond continued, "Blockbuster content from Hollywood, China, India and South Korea will hit IMAX screens across the globe this year. Expanding our content offering by including more local-language titles is a key initiative of the Company, given our 1,300-plus screens span nearly 80 countries. We believe that tailoring our slate to the varying consumer preferences in diverse markets such as China will increase the box office productivity of our network. In addition to the compelling mix of global blockbusters, we are also confident that the launch of our new global brand campaign will more effectively communicate to consumers the benefits of the premium IMAX experience. We expect the new brand campaign, combined with the launch of IMAX with Laser and our growing global footprint, to drive incremental attendance at IMAX screens around the world."

Second Quarter Segment Results

Network Business

  • Network business revenues were $60.9 million in the quarter, compared with $47.4 million in the prior-year period. Gross margin for the network business were 70.5% in the most recent quarter, compared to 66.3% in the prior-year period. The increase in revenue and gross margin was primarily driven by a 27.4% increase in box office.
  • IMAX DMR revenues were $36.2 million in the second quarter of 2018, compared to $27.8 million in the second quarter of 2017. Gross margin for the IMAX DMR segment was 67.1%, compared to 61.2% in the prior-year comparative period.
  • Revenue from joint revenue-sharing arrangements were $24.7 million in the quarter, compared with $18.9 million in the prior-year period.  Gross margin for joint revenue-sharing arrangements was 75.3%, compared to 72.3% in the prior-year comparative period.

Theater Business

  • Theater business segment revenues were $30.9 million in the quarter, compared with $32.7 million in the prior-year period, primarily reflecting the installation of 3 fewer sales-type theaters.
  • Gross margin on sales and sales-type leases was 57.6% compared with 60.3% in the year-ago period. The decrease in the recent period is primarily the result of three fewer system installations compared to the prior year period.

Supplemental Materials
For more information about the Company's results, please refer to the IMAX Investor Relations website located at investors.imax.com.

Investor Relations Website and Social Media
On a weekly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at www.imax.com/content/investor-relations. The Company expects to provide such updates on Friday of each week, although the Company may change this timing without notice. Results will be displayed with a one-week lag. In addition, the Company maintains a Twitter account: @IMAX_Investors. The Company intends to use Twitter to disclose the box office information, as well as other information that may be of interest to the Company's investor community.

The information posted on the Company's website and/or via its Twitter account may be deemed material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website and its Twitter account in addition to the Company's press releases, SEC filings and public conference calls and webcasts.

Conference Call
The Company will host a conference call today at 4:30PM ET to discuss its second quarter 2018 financial results. This call is being webcast by Nasdaq and can be accessed at investors.imax.com. To access the call via telephone, interested parties in the US and Canada should dial (800) 263-0877 approximately 5 to 10 minutes before the call begins. Other international callers should dial (438) 968-3557. The conference ID for the call is 5362019. A replay of the call will be available via webcast at investors.imax.com or via telephone by dialing (888) 203-1112 (US and Canada), or (647) 436-0148 (international). The Conference ID for the telephone replay is 5362019.         

About IMAX Corporation
IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you've never imagined. Top filmmakers and studios are utilizing IMAX theaters to connect with audiences in extraordinary ways, and, as such, IMAX's network is among the most important and successful theatrical distribution platforms for major event films around the globe.

IMAX is headquartered in New York, Toronto and Los Angeles, with additional offices in London, Dublin, Tokyo, and Shanghai. As of June 30, 2018, there were 1,410 IMAX theater systems (1,314 commercial multiplexes, 12 commercial destinations, 84 institutional) operating in 79 countries. On Oct. 8, 2015, shares of IMAX China, a subsidiary of IMAX Corp., began trading on the Hong Kong Stock Exchange under the stock code "HK.1970."

IMAX®, IMAX® 3D, IMAX DMR®, Experience It In IMAX®, An IMAX 3D Experience®, The IMAX Experience®, IMAX Is Believing® and IMAX nXos® are trademarks of IMAX Corporation. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).

This press release contains forward looking statements that are based on IMAX management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, references to future capital expenditures (including the amount and nature thereof), business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, plans and references to the future success of IMAX Corporation together with its consolidated subsidiaries (the "Company") and expectations regarding the Company's future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada; risks related to the Company's growth and operations in China; the performance of IMAX DMR films; the signing of theater system agreements; conditions, changes and developments in the commercial exhibition industry; risks related to currency fluctuations; the potential impact of increased competition in the markets within which the Company operates; competitive actions by other companies; the failure to respond to change and advancements in digital technology; risks relating to recent consolidation among commercial exhibitors and studios; risks related to new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to cyber-security; risks related to the Company's inability to protect the Company's intellectual property; general economic, market or business conditions; the failure to convert theater system backlog into revenue; changes in laws or regulations; the failure to fully realize the projected cost savings and benefits from the Company's restructuring initiative; and other factors, many of which are beyond the control of the Company. These factors, other risks and uncertainties and financial details are discussed in IMAX's most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

For additional information please contact:

Investors:

IMAX Corporation, New York

Michael K. Mougias

212-821-0187

mmougias@imax.com

 

 

Media:

IMAX Corporation, New York

Amanda Collins

212-821-0155

abcollins@imax.com

 

 

 

Additional Information

Signings and Installations






June 30, 2018








Three Months

Ended June 30,




Theater Signings:

2018


2017




Full new sales and sales-type lease arrangements

9


14




New traditional joint revenue sharing arrangements

31


31




New hybrid joint revenue sharing lease arrangements

-


47




Total new theaters

40


92




Upgrades of IMAX theater systems

98


3




Total Theater Signings

138


95












Three Months

Ended June 30,




Theater Installations:

2018


2017




Full new sales and sales-type lease arrangements

9


12




New traditional joint revenue sharing arrangements

19


18




New hybrid joint revenue sharing lease arrangements

2


3




Total new theaters

30


33




Upgrades of IMAX theater systems

1

(1)

1

(1)



Total Theater Installations

31


34












Three Months

Ended June 30,








Theater Backlog:

2018


2017




New sales and sales-type lease arrangements

181

(2)

174




New joint revenue sharing arrangements







Hybrid lease arrangements

115


137




Traditional arrangements

339


269




Total Theater Backlog

635

(3)

580

(4)











Three Months

Ended June 30,








Theater Network:

2018


2017




Commercial Multiplex Theaters:







Sales and sales-type lease arrangements

576

(5)

483




Traditional joint revenue sharing arrangements

628


554




Hybrid joint revenue sharing lease arrangements

110


117




Total Commercial Multiplex Theaters

1,314


1,154




Commercial Destination Theaters

12


13




Institutional Theaters

84


90




Total Theater Network

1,410


1,257



______________________

(1)

Includes one installation of an upgrade to a laser-based digital system under a joint revenue (2017 – one under a sales arrangement).

(2)

Includes 22 hybrid sales theater systems which were previously classified under joint revenue sharing arrangements – hybrid sales arrangements.

(3)

Includes 75 new laser projection system configurations, including 101 upgrades of existing locations to laser projection system configurations (99 of these 101 are for the new next generation laser projection system configurations).

(4)

Includes 24 laser projection system configurations and four upgrades of existing locations to laser projection system configurations.

(5)

Includes 35 theater systems which were previously classified under joint revenue sharing arrangements – hybrid sales arrangements. See "Critical Accounting Policies and estimates" in the form 10-Q for further details of the adoption impact of ASC Topic 606 on the Company's revenues.


 

IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands of U.S. dollars, except per share amounts)

(Unaudited)


















Three Months Ended


Six Months Ended




June 30,


June 30,




2018


2017


2018


2017

Revenues













Equipment and product sales


$

15,368


$

21,334


$

34,881


$

32,879

Services



54,785



44,603



99,531



83,447

Rentals



25,124



19,438



43,326



35,294

Finance income



3,068



2,383



5,591



4,794





98,345



87,758



183,329



156,414

Costs and expenses applicable to revenues













Equipment and product sales



7,549



11,453



15,521



18,917

Services



23,633



21,266



43,984



41,080

Rentals



6,759



5,580



12,728



11,187





37,941



38,299



72,233



71,184

Gross margin



60,404



49,459



111,096



85,230

Selling, general and administrative expenses



32,608



28,589



60,691



59,531


(including share-based compensation expense of $6.2 million and $10.7 million for the three and six months ended June 30, 2018 (2017 — $6.2 million and $11.0 million, respectively))












Research and development



3,922



5,678



7,514



10,012

Asset impairments



-



1,225



-



1,225

Amortization of intangibles



965



779



1,857



1,380

Receivable provisions, net of recoveries



355



940



806



1,125

Legal arbitration award



7,500



-



7,500



-

Exit costs, restructuring charges and associated impairments



456



10,258



1,158



10,258

Income from operations



14,598



1,990



31,570



1,699

Interest income



243



280



490



508

Interest expense



(851)



(435)



(1,345)



(890)

Income from operations before income taxes



13,990



1,835



30,715



1,317

(Provision for) recovery of income taxes



(3,635)



238



(8,088)



124

Loss from equity-accounted investments, net of tax



(100)



(264)



(305)



(519)

Net income



10,255



1,809



22,322



922

Less: income loss attributable to non-controlling interests



(2,630)



(3,521)



(6,192)



(2,559)

Net income (loss) attributable to common shareholders


$

7,625


$

(1,712)


$

16,130


$

(1,637)















Net income (loss) per share attributable to common shareholders - basic and diluted:










Net income (loss) per share — basic and diluted


$

0.12



(0.03)


$

0.25


$

(0.02)















Weighted average number of shares outstanding (000's):














Basic



63,314



65,793



63,931



66,076


Fully Diluted



63,426



65,992



64,006



66,548















Additional Disclosure:













Depreciation and amortization(1)


$

14,513


$

13,266


$

28,034


$

25,354















(1) Includes $0.4 million and $0.5 million of amortization of deferred financing costs charged to interest expense for the three and six months ended June 30, 2018, respectively (2017 - $0.2 million and $0.3 million, respectively).

 

 

 

IMAX CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands of U.S. dollars)

(Unaudited)


















June 30,


December 31,


2018


2017






Assets






Cash and cash equivalents

$

133,042


$

158,725

Accounts receivable, net of allowance for doubtful accounts of $2,348 (December 31, 2017 — $1,613)


113,461



130,546

Financing receivables


125,756



129,494

Inventories


40,705



30,788

Prepaid expenses


9,401



7,549

Film assets


15,193



5,026

Property, plant and equipment


276,129



276,781

Other assets


61,956



26,757

Deferred income taxes


24,386



30,708

Other intangible assets


30,456



31,211

Goodwill


39,027



39,027

Total assets

$

869,512


$

866,612







Liabilities






Bank indebtedness

$

24,377


$

25,357

Accounts payable


15,027



24,235

Accrued and other liabilities


107,799



100,140

Deferred revenue


110,286



113,270

Total liabilities


257,489



263,002







Commitments and contingencies












Non-controlling interests


7,578



1,353







Shareholders' equity






Capital stock common shares — no par value. Authorized — unlimited number.






62,747,512 issued and 62,521,916 outstanding (December 31, 2017 — 64,902,201 issued and 64,695,550 outstanding)


431,003



445,797

Less: Treasury stock, 225,596 shares at cost (December 31, 2017 — 206,651)


(4,636)



(5,133)

Other equity


179,767



175,300

Accumulated deficit


(75,908)



(87,592)

Accumulated other comprehensive loss


(2,762)



(626)

Total shareholders' equity attributable to common shareholders


527,464



527,746

Non-controlling interests


76,981



74,511

Total shareholders' equity


604,445



602,257

Total liabilities and shareholders' equity

$

869,512


$

866,612


 

IMAX CORPORATION


CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS


(In thousands of U.S. dollars)


(Unaudited)




Six Months Ended June 30,




2018


2017









Cash provided by (used in):







Operating Activities








Net income


$

22,322


$

922


Adjustments to reconcile net income to cash from operations:








Depreciation and amortization



28,034



25,354


Write-downs, net of recoveries



1,686



13,155


Change in deferred income taxes



347



(3,133)


Stock and other non-cash compensation



11,920



12,570


Unrealized foreign currency exchange gain



473



(462)


Loss from equity-accounted investments



106



321


Loss on non-cash contribution to equity-accounted investees



199



198


Investment in film assets



(18,219)



(19,589)


Changes in other non-cash operating assets and liabilities



(214)



7,884


Net cash provided by operating activities



46,654



37,220










Investing Activities








Purchase of property, plant and equipment



(8,632)



(9,771)


Investment in joint revenue sharing equipment



(8,455)



(17,550)


Acquisition of other intangible assets



(1,705)



(2,624)


Investment in new business ventures



-



(1,500)


Net cash used in investing activities



(18,792)



(31,445)










Financing Activities








Repayment of bank indebtedness



(1,000)



(1,000)


Repurchase of common shares



(46,452)



(46,138)


Treasury stock purchased for future settlement of restricted share units



(4,636)



(5,412)


Taxes withheld and paid on employee stock awards vested



(1,279)



(187)


Settlement of restricted share units and options



(1,529)



(14,048)


Issuance of subsidiary shares to a non-controlling interest



6,696



-


Common shares issued - stock options exercised



799



14,419


Credit facility amendment fees paid



(1,963)



-


Dividends paid to non-controlling interests



(4,623)



-


Net cash used in financing activities



(53,987)



(52,366)










Effects of exchange rate changes on cash



442



76










Decrease in cash and cash equivalents during period



(25,683)



(46,515)










Cash and cash equivalents, beginning of period



158,725



204,759










Cash and cash equivalents, end of period


$

133,042


$

158,244











 

 

 

IMAX CORPORATION

SELECTED FINANCIAL DATA

In accordance with United States Generally Accepted Accounting Principles

(in thousands of U.S. dollars)


The Company has four primary reporting groups identified by nature of product sold or service provided: (1) Network Business, representing variable revenue generated by box-office results and which includes the reportable segments of IMAX DMR and contingent rent from the JRSAs and IMAX systems segments; (2) Theater Business, representing revenue generated by the sale and installation of theater systems and maintenance services, primarily related to the IMAX Systems and Theater System Maintenance reportable segments, and also includes fixed hybrid revenues and upfront installation costs from the JRSA segment; (3) New Business, which includes content licensing and distribution fees associated with our original content investments, virtual reality initiatives, IMAX Home Entertainment, and other business initiatives that are in the development and/or start-up phase, and (4) Other; which includes the film post-production and distribution segments and certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items.







Three Months


Six Months






Ended June 30,


Ended June 30,







2018



2017


2018


2017

Revenue














Network Business















IMAX DMR



$

36,161


$

27,757


$

63,214


$

51,166


Joint revenue sharing arrangements – contingent rent




24,730



18,896



42,593



34,130


IMAX systems – contingent rent




-



790



-



1,478







60,891



47,443



105,807



86,774

Theater Business














IMAX systems
















Sales and sales-type leases




11,981



16,125



30,118



23,067



Ongoing fees and finance income




3,282



2,613



6,012



5,198


Joint revenue sharing arrangements – fixed fees




1,022



1,408



1,022



1,878


Theater system maintenance




12,335



10,904



25,047



21,949


Other theater




2,255



1,699



3,631



3,864







30,875



32,749



65,830



55,956

New Business




3,116



1,311



3,723



2,591

















Other















Film distribution and post-production




2,360



5,087



6,094



8,670


Other




1,103



1,168



1,875



2,423







3,463



6,255



7,969



11,093

Total



$

98,345


$

87,758


$

183,329


$

156,414

















Gross margin














Network Business















IMAX DMR(1)



$

24,280


$

16,998


$

43,063


$

34,466


Joint revenue sharing arrangements – contingent rent(1)




18,621



13,668



31,362



23,920


IMAX systems – contingent rent




-



790



-



1,478







42,901



31,456



74,425



59,864

Theater Business















IMAX systems
















Sales and sales-type leases




6,899



9,724



18,508



12,944



Ongoing fees and finance income




3,234



2,539



5,917



5,060


Joint revenue sharing arrangements – fixed fees(1)




246



176



246



264


Theater system maintenance




5,088



4,434



11,292



8,683


Other theater




563



405



517



834







16,030



17,278



36,480



27,785

New Business




1,906



(1,183)



436



(1,520)

















Other















Film distribution and post-production(1)




(387)



1,998



59



(665)


Other




(46)



(90)



(304)



(234)







(433)



1,908



(245)



(899)

Total



$

60,404


$

49,459


$

111,096


$

85,230



(1)

IMAX DMR segment margins include marketing costs of $6.5 million and $10.6 million for the three and six months ended June 30, 2018, respectively (2017 - $4.7 million and $7.3 million, respectively). Joint revenue sharing arrangements segment margins include advertising, marketing and commission costs of $1.0 million and $1.2 million for the three and six months ended June 30, 2018, respectively (2017 - $0.8 million and $1.2, respectively). IMAX system sales and sales-type lease segment margins include marketing and commission costs of $0.5 million and $1.2 million for the three and six months ended June 30, 2018, respectively (2017 - $0.8 million and $1.1 million). Film distribution and post production segment margins include marketing expense of $0.8 million and $2.0 million for the three and six months ended June 30, 2018 (2017 - recovery of $0.6 million and $0.7 million, respectively).

 

 

IMAX CORPORATION

OTHER INFORMATION

 (in thousands of U.S. dollars)


Non-GAAP Financial Measures:


In this release, the Company presents adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share, EBITDA and adjusted EBITDA as supplemental measures of performance of the Company, which are not recognized under U.S. GAAP. The Company presents adjusted net income and adjusted net income per diluted share because it believes that they are important supplemental measures of its comparable controllable operating performance and it wants to ensure that its investors fully understand the impact of its stock-based compensation (net of any related tax impact) on net income. In addition, the Company presents adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share because it believes that they are important supplemental measures of its comparable financial results and could potentially distort the analysis of trends in business performance and it wants to ensure that its investors fully understand the impact of net income attributable to non-controlling interests and its stock-based compensation (net of any related tax impact) in determining net income attributable to common shareholders. Management uses these measures to review operating performance on a comparable basis from period to period. However, these non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share should be considered in addition to, and not as a substitute for, net income and net income attributable to common shareholders and other measures of financial performance reported in accordance with U.S. GAAP.


Management uses "EBITDA", as such term is defined in the Company's credit agreement (and which is referred to herein as "Adjusted EBITDA per Credit Facility", as the credit agreement includes additional adjustments beyond interest, taxes, depreciation and amortization). Adjusted EBITDA  per Credit Facility (each as defined below) should not be construed as substitutes for net income or as better measures of liquidity as determined in accordance with U.S. GAAP.  The Company believes that Adjusted EBITDA per Credit Facility is relevant and useful information widely used by analysts, investors and other interested parties in the Company's industry.




For the


For the




3 months ended


12 months ended



June 30, 2018


June 30, 2018

(1)

(In thousands of U.S. Dollars)







Net income

$

10,255


$

33,918


Add (subtract):








Provision for income taxes


3,635



25,002



Interest expense, net of interest income


608



1,388



Depreciation and amortization, including film asset amortization


14,513



69,488



EBITDA

$

29,011


$

129,796



Stock and other non-cash compensation


6,779



23,141



Write-downs, net of recoveries including asset impairments and








receivable provisions


650



18,099



Exit costs, restructuring charges and associated impairments


456



7,074



Legal arbitration award


7,500



7,500



Loss from equity accounted investments


100



489



Adjusted EBITDA before non-controlling interests(2)

$

44,496


$

186,099



Adjusted EBITDA attributable to non-controlling interests


(5,014)



(24,404)



Adjusted EBITDA per Credit Facility

$

39,482

*

$

161,695

*


Adjusted EBITDA per Credit Facility, excluding impact from "Marvel's Inhumans"

$

39,489

*

$

148,930

*


Adjusted revenues attributable to common shareholders (3)

$

90,860


$

367,281



Adjusted EBITDA margin, excluding impact from "Marvel's Inhumans"


43.5

%


40.5

%









* Adjusted EBITDA per Credit Facility of $39.5 million and $161.7 million for the three and twelve months ended June 30, 2018 respectively, include the impact of the Company's investment in "Marvel's Inhumans", which resulted in a less than $0.1 million and $12.2 million loss, respectively. However, as permitted by the Credit Facility, this loss was offset by addbacks of $nil and $13.3 million for amortization and by addbacks of, $nil and $11.7 million for impairment charges relating to the investment, in each case for the three and twelve months ended June 30, 2018, respectively. The net effect of these addbacks was to increase Adjusted EBITDA per Credit Facility by less than $0.1 million and $12.8 million for the three and twelve months ended June 30, 2018, respectively. This investment represents the Company's first foray into a commercial television property, and therefore the Adjusted EBITDA per Credit Facility

__________________



(1)

Ratio of funded debt calculated using twelve months ended Adjusted EBITDA per Credit Facility.



(2)

The Adjusted EBITDA per Credit Facility calculation specified for purpose of the minimum Adjusted EBITDA covenant excludes the reduction in Adjusted EBITDA from the Company's non-controlling interests.



(3)



3 months ended June 30, 2018


12 months ended June 30, 2018


Total revenues




$

98,345




$

407,681


Greater China revenues


$


23,341




$


126,389




Non-controlling interest ownership percentage(4)



32.07%






31.96%





Deduction for non-controlling interest share of revenues





(7,485)





(40,400)


Adjusted revenues attributable to common shareholders




$

90,860




$

367,281


(4)

Weighted average ownership percentage for change in non-controlling interest share

 

 


IMAX CORPORATION

OTHER INFORMATION

(in thousands of U.S. dollars)


Adjusted Net Income and Adjusted Diluted Per Share Calculations – Quarter Ended June 30, 2018 vs. 2017:


The Company reported net income of $10.3 million, which calculates to $0.16 per basic and diluted share, for the second quarter of 2018 as compared to a net income of $1.8 million, $0.03 per basic and diluted share for the second quarter of 2017.


Net income for the second quarter of 2018 includes a $6.8 million charge, or $0.10 per diluted share (2017 — $6.8 million or $0.10 per diluted share), for stock-based compensation and a $0.5 million charge, or $0.01 per diluted share for exit costs, restructuring charges and associated impairments (2017 - $10.3 million or $0.15 per diluted share), and a $7.5 million charge, or $0.12 per diluted share, for a legal arbitration award related to one of the Company's litigation matters from 2006 (2017 - $nil or $nil per diluted share).


Adjusted net income, which consists of net income excluding the impact of stock-based compensation, exit costs, restructuring charges and associated impairments, the legal arbitration award and the related tax impact, was $21.7 million, or $0.34 per diluted share, for the second quarter of 2018 as compared to adjusted net income of $13.5 million, or $0.20 per diluted share, for the second quarter of 2017.


The Company reported net income attributable to common shareholders of $7.6 million, or $0.12 per basic and diluted share for the second quarter of 2018 (2017 — loss of $1.7 million or $0.03 per basic and diluted share).


Adjusted net income attributable to common shareholders, which consists of net income attributable to common shareholders excluding the impact of stock-based compensation, exit costs, restructuring charges and associated impairments, the legal arbitration award and the related tax impact, was $19.0 million, or $0.30 per diluted share, for the second quarter of 2018 as compared to adjusted net income attributable to common shareholders of $9.6 million, or $0.15 per diluted share, for the second quarter of 2017.


A reconciliation of net income and net income attributable to common shareholders, the most directly comparable U.S. GAAP measure, to adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below:


(In thousands of U.S. dollars, except per share amounts)

Quarter Ended June 30,


2018



2017




Net Income


Diluted EPS



Net Income


Diluted EPS


Reported net income

$

10,255


$

0.16



$

1,809


$

0.03


Adjustments:















Stock-based compensation


6,756



0.10




6,793



0.10



Exit costs, restructuring charges and associated impairments


456



0.01




10,258



0.15



Legal arbitration award


7,500



0.12




-



-



Tax impact on items listed above


(3,228)



(0.05)




(5,382)



(0.08)


Adjusted net income


21,739



0.34




13,478



0.20



Net (income) loss attributable to non-controlling interests


(2,630)



(0.04)




(3,521)



(0.05)


Stock-based compensation (net of tax of less than















$0.1 million and less than $0.1 million, respectively) 


(147)



-




(153)



-


Exit costs, restructuring charges and associated















  impairments (net of tax of less than $0.1 million)


-



-




(168)



-


Adjusted net income attributable to common shareholders

$

18,962


$

0.30



$

9,636


$

0.15

















Weighted average diluted shares outstanding





63,426







65,992






































 

Adjusted Net Income and Adjusted Diluted Per Share Calculations – Six Months Ended June 30, 2018 vs. 2017:


The Company reported net income of $22.3 million, or $0.35 per basic and diluted share, for the six months ended June 30, 2018 as compared to net income of $0.9 million, or $0.01 per basic and diluted share for the six months ended June 30, 2017.


Net income for the six months ended June 30, 2018 includes a $11.6 million charge, or $0.18 per diluted share (2017 — $12.1 million or $0.18 per diluted share) for stock-based compensation, and a $1.2 million charge, or $0.02 per diluted share for exit costs, restructuring charges and associated impairments (2017 — $10.3 million, or $0.15 per diluted share), and a $7.5 million charge, or $0.12 per diluted share for a legal arbitration award related to one of the Company's litigation matters from 2006 (2017 - $nil or $nil per diluted share).


Adjusted net income, which consists of net income excluding the impact of stock-based compensation, exit costs, restructuring charges and associated impairments, the legal arbitration award and the related tax impact, was $38.8 million, or $0.61 per diluted share, for the six months ended June 30, 2018 as compared to adjusted net income of $16.5 million, or $0.24 per diluted share, for the six months ended June 30, 2017.


The Company reported a net income attributable to common shareholders of $16.1 million, or $0.25 per basic and diluted share for the six months ended June 30, 2018 (2017 — net loss of $1.6 million, or a loss of $0.02 per basic and diluted share).


Adjusted net income attributable to common shareholders, which consists of net income attributable to common shareholders excluding the impact of stock-based compensation, exit costs, restructuring charges and associated impairments, the legal arbitration award and the related tax impact, was $32.4 million, or $0.51 per diluted share, for the six months ended June 30, 2018 as compared to adjusted net income attributable to common shareholders of $13.5 million, or $0.20 per diluted share, for the six months ended June 30, 2017.


A reconciliation of net income and net income attributable to common shareholders, the most directly comparable U.S. GAAP measure, to adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below:

(In thousands of U.S. dollars, except per share amounts)

Six Months Ended June 30,


2018


2017




Net Income


Diluted EPS


Net Income


Diluted EPS


Reported net income

$

22,322


$

0.35


$

922


$

0.01


Adjustments:














Stock-based compensation


11,603



0.18



12,057



0.18



Exit costs, restructuring charges and associated impairments


1,158



0.02



10,258



0.15



Legal arbitration award


7,500



0.12



-



-



Tax impact on items listed above


(3,787)



(0.06)



(6,723)



(0.10)


Adjusted net income


38,796



0.61



16,514



0.24



Net (income) loss attributable to non-controlling interests


(6,192)



(0.10)



(2,559)



(0.04)



Stock-based compensation (net of tax of $0.1 million and














$0.1 million, respectively)


(204)



-



(281)



-



Exit costs, restructuring charges and associated impairments














(net of tax of less than $0.1 million)


-



-



(168)



-


Adjusted net income attributable to common shareholders

$

32,400


$

0.51


$

13,506


$

0.20
















Weighted average diluted shares outstanding





64,006






66,548
















 

 

Free Cash Flow:


Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the consolidated statements of cash flows). Cash provided by operating activities consist of net income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company's after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented in the table below:





For the


For the




Three months ended


Six months ended



June 30, 2018


June 30, 2018

(In thousands of U.S. Dollars)







Net cash provided by operating activities


$

31,191


$

46,654

Net cash used in investing activities



(6,839)



(18,792)


Net cash flow


$

24,352


$

27,862

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/imax-corporation-reports-second-quarter-2018-results-300686583.html

SOURCE IMAX Corporation

View Comments and Join the Discussion!